Table 2 Clinical pathologic characteristics of the cohort
Level | Overall(1642) | ER(787) | NER(855) | P-value | |
|---|---|---|---|---|---|
Age* | 43.69 (11.50) | 43.36 (11.11) | 44.00 (11.86) | 0.255 | |
Gender (%) | Male | 480 (29.2) | 169 (21.5) | 311 (36.4) | < 0.001 |
Female | 1162 (70.8) | 618 (78.5) | 544 (63.6) | ||
Pathology type (%) | Papillary carcinoma | 1633 (99.5) | 784 (99.6) | 849 (99.3) | 0.586 |
Follicular carcinoma | 9 (0.5) | 3 (0.4) | 6 (0.7) | ||
Capsular invasion (%) | No | 1145 (69.7) | 562 (71.4) | 583 (68.2) | 0.172 |
Yes | 497 (30.3) | 225 (28.6) | 272 (31.8) | ||
Metastasis number # | 3 [2, 7] | 3 [1, 5] | 4 [2, 8] | < 0.001 | |
Benign lesion (%) | No | 696 (42.4) | 305 (38.8) | 391 (45.7) | 0.005 |
Yes | 946 (57.6) | 482 (61.2) | 464 (54.3) | ||
TNM tumor stage (%) | I | 1382 (84.2) | 670 (85.1) | 712 (83.3) | 0.336 |
II-III | 260 (15.8) | 117 (14.9) | 143 (16.7) | ||
ATA risk stratification (%) | Low risk | 402 (24.5) | 303 (38.5) | 99 (11.6) | < 0.001 |
Intermediate-high risk | 1240 (75.5) | 484 (61.5) | 756 (88.4) | ||
Tg (ng/mL) # | 2.2 [0.6,7.1] | 0.9 [0.2, 2.2] | 5.7 [2.0, 16.7] | < 0.001 | |
Tg/TSH (ng/mIU) # | 24.7 [5.8,83.7] | 9.7 [2.3, 25.4] | 64.8 [20.3, 192.6] | < 0.001 |